Clover Health Investments, Corp.

NASDAQ:CLOV

Medical - Healthcare Plans

Healthcare
$4.17 +3.54%

+$0.17 today

Market cap
$2.21B
Beta
2.48
P/E (TTM)
-45.6
EPS (TTM)
-$0.11
52W Low $1.58High $5.18

Volume 8.05M

Average 7.31M

CLOV EBITDA

Earnings before interest, taxes, depreciation, and amortization; a proxy for operating profit before non-cash and financing charges.

Clover Health Investments, Corp.NASDAQ: CLOV

EBITDA · Q2 FY2026 · quarter ended Jun 2026

EBITDA turns positive

Q2 FY2026 EBITDA was $28.57M, compared with -$10.18M a year earlier. Trailing-twelve-month EBITDA was -$16.46M.

Context

  • EBITDA amounted to 4.4% of revenue in FY2025, up 1.1 pp from a year earlier.
  • EBITDA grew in size in 1 of the last 3 fiscal years.

What to watch

Whether EBITDA reaches the consensus estimate from 3 analysts of $41.46M (+149.4%) for the fiscal year ending Dec 2026, a step up from the -86.6% reported in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterJun 2026
$28.57M+2.6% QoQ
Last fiscal yearDec 2025
-$83.86M-86.6% YoY
LTMJun 2026
-$16.46M+60.0% YoY
EBITDA past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+380.5%+90.8%-289.7 pp
1 year-86.6%+149.4%+236.1 pp
3-year CAGR———
5-year CAGR——
10-year CAGR——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

EBITDA history

USD · from the income statement

Latest · FY2025
(83.86M) USD
Year-over-year change
-86.6%
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

EBITDA vs competitors

How CLOV compares with its peers on the latest reported figures

  • CLOV's LTM Jun 2026 EBITDA of -$16.46M is the 6th highest of the 7 companies compared; the peer median is $1.94B.
  • Its year-over-year change of +60.0% is the 3rd highest of 7, against a peer median of +2.9%.
  • EBITDA amounts to 0.7% of revenue for CLOV, versus a peer median of 2.7%.
CLOV Competitors Peer median
EBITDA for CLOV and competitors
Company Period LTM YoY 3-year CAGR% of revenue
CVSCVS Health CorporationLTM Jun 2026$13.41B -5.4%-7.2%3.2%
CICigna CorporationLTM Sep 2026$12.53B +1.2%+0.7%4.4%
HUMHumana Inc.LTM Sep 2026$3.24B +4.5%-15.4%2.1%
OSCROscar Health, Inc.LTM Jun 2026$633.7M +751.9%—4.1%
ALHCAlignment Healthcare, Inc.LTM Mar 2026$66.42M +265.7%—1.6%
CLOVClover Health Investments, Corp.LTM Jun 2026-$16.46M +60.0%—0.7%
CNCCentene CorporationLTM Jun 2026-$2.73B -158.1%—1.4%
Peer median (excluding CLOV) $1.94B+2.9%-7.2%2.7%

Competitors are the stored peer set for CLOV. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue1.47B1.1B1.26B1.37B1.92B
Cost of Revenue1.55B993.07M1B1.01B1.57B
Gross Profit(79.18M)103.48M255.95M364.8M355.88M
Gross Margin-5.4%9.4%20.3%26.6%18.5%
Research & Development00000
Selling, General & Admin445.75M482.4M440.25M408.93M176.32M
Operating Expenses557.81M390.14M461.28M410.55M441.43M
Depreciation & Amortization1.25M1.19M2.51M1.33M1.69M
EBITDA(569.6M)(252.03M)(207.63M)(44.94M)(83.86M)
EBITDA Margin-38.7%-23.0%-16.5%-3.3%-4.4%
Operating Income(636.99M)(286.66M)(205.33M)(45.75M)(85.53M)
Operating Margin-43.3%-26.1%-16.3%-3.3%-4.4%
Interest Income00000
Interest Expense16.91M1.36M7K00
Other Income / Expenses49.24M32.08M(4.82M)(517K)(20K)
Income Before Tax(587.76M)(254.58M)(210.15M)(46.27M)(85.55M)
Pre-Tax Margin-39.9%-23.2%-16.7%-3.4%-4.4%
Income Tax Expense00000
Net Income(587.76M)(339.57M)(213.36M)(43.01M)(85.55M)
Net Margin-39.9%-31.0%-16.9%-3.1%-4.4%
EPS (Basic)(1.25)(0.71)(0.45)(0.09)(0.17)
EPS (Diluted)(1.25)(0.71)(0.45)(0.09)(0.17)
Weighted Avg Shares470.85M476.24M482.18M490.02M517.24M
Weighted Avg Shares (Diluted)470.85M476.24M482.18M490.02M517.24M

Clover Health Investments, Corp.

NASDAQ:CLOV

Intrinsic Alpha fair value

Locked

Current Price

$4.17

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.